Nebivolol Hcl
Rank #301 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$38.2M
Total Cost
421,756
Total Claims
$38.2M
Total Cost
14,944
Prescribers
$91
Cost per Claim
52,815
Beneficiaries
905,786
30-Day Fills
$2,557
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$38.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $38.2M total
Top Prescribers of Nebivolol Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Gary Reznik | Cardiology | Los Angeles, CA | 2,902 | $248K |
| 2 | Gary Reznik | Cardiology | Los Angeles, CA | 459 | $120K |
| 3 | Gerald Mancuso | Cardiology | Kansas City, MO | 755 | $73K |
| 4 | Adel Sidky | Cardiology | Boynton Beach, FL | 638 | $69K |
| 5 | Afshine Emrani | Cardiology | Tarzana, CA | 520 | $68K |
| 6 | Vlad Nusinovich | Internal Medicine | West Hollywood, CA | 830 | $64K |
| 7 | Durga Madala | Cardiology | San Jose, CA | 564 | $64K |
| 8 | Ngoc An Phan | Internal Medicine | Philadelphia, PA | 176 | $63K |
| 9 | Anna Milstein | Cardiology | Los Angeles, CA | 659 | $60K |
| 10 | Tao Duong | Cardiology | Westminster, CA | 331 | $59K |
| 11 | Garo Pehlevanian | Cardiology | Los Angeles, CA | 699 | $58K |
| 12 | William Craig | Cardiology | Gonzales, TX | 880 | $55K |
| 13 | Jennifer Rodriguez | Interventional Cardiology | Meridian, MS | 642 | $48K |
| 14 | Christakis Christodoulou | Cardiology | Pasadena, CA | 523 | $47K |
| 15 | Henry Yee | Cardiology | Alhambra, CA | 390 | $46K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 298 | Propranolol Hcl (Propranolol Hcl) | $38.7M | 1,168,547 |
| 299 | Icatibant Acetate (Icatibant) | $38.4M | 831 |
| 300 | Dextroamphetamine/Amphetamine (Dextroamphetamine-Amphetamine) | $38.2M | 706,329 |
| 301 | Nebivolol Hcl (Nebivolol Hcl) | $38.2M | 421,756 |
| 302 | Cinacalcet Hcl (Cinacalcet Hcl) | $37.9M | 76,761 |
| 303 | Risperidone (Risperidone) | $37.4M | 1,480,207 |
| 304 | Prednisone (Prednisone) | $37.3M | 5,970,737 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology